期刊文献+

中药复方益糖康对STZ大鼠PKC mRNA表达的影响 被引量:1

The Effect of Chinese Herbal Compound Yitangkang on PKC Mrna Expression of STZ Rats
下载PDF
导出
摘要 目的:探讨中药复方益糖康对STZ大鼠蛋白激酶C(PKC)mRNA表达的影响。方法:采用STZ腹腔注射方法复制糖尿病大鼠模型,随机分为空白对照组、安慰剂组和益糖康组,灌胃6周后,采集大鼠背根神经节(DRG)标本,RT-PCR方法检测其PKC mRNA表达水平。结果:安慰剂组大鼠DRG中PKC mRNA表达水平显著上调,益糖康组较安慰剂组PKC mRNA表达水平显著降低。结论:中药复方益糖康可能抑制PKC激活,是其治疗糖尿病及其并发症的机制之一。 Objective:To explore the effect of Chinese herbal compound Yitangkang on protein kinase C(PKC)mRNA expression of STZ rats.Methods:Diabetic rat model was reproduced by intraperitoneal injection of STZ,and they were randomly divided into control group,placebo group and Yitangkang group,using gavage for 6 weeks,then rat dorsal root ganglion(DRG)samples were collected,RT-PCR was used to detect the protein levels of PKC.Results:The placebo group PKC mRNA levels in DRG were significantly increased,compared with the placebo group,mRNA levels of PKC in Yitangkang group were significantly reduced.Conclusion:Chinese herbal compound Yitangkang may inhibit PKC activation,which may be one of the mechanisms of its treatment of diabetes and complications.
机构地区 辽宁中医药大学
出处 《辽宁中医杂志》 CAS 2012年第7期1419-1420,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 辽宁省科技厅资助项目(20082063)
关键词 糖尿病 背根神经节 蛋白激酶C mRNA diabetes mellitus dorsal root ganglia protein kinase C mRNA
  • 相关文献

参考文献2

二级参考文献16

  • 1吕妍,王新,唐方.六味地黄制剂对糖尿病肾病大鼠肾功能的影响[J].中草药,2005,36(9):1379-1380. 被引量:7
  • 2Koya D, King G L. Protein kinase C activation and the development of diabetic complications [J]. Diabetes, 1998, 47: 859 -866.
  • 3Idris I, Gray S, Donnelly R. Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes [J]. Diabetologia, 2001, 44 (6) : 659- 673.
  • 4Craven P A, De Rubertis F R. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose [J]. J Clin Invest, 1989, 8:3 (5): 1667-1675.
  • 5Kagami S, Border W A, Miller D E, et al. Angiotensin Ⅱ stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells [J]. J Clin Invest, 1994, 93(6): 2421-2427.
  • 6Singh R, Song R H, Alavi N, et al. High glucose decrease matrix metalloproteinase -2 activity in rat mesangial cells rat via transforming growth factor-beta [J]. Exp Nephrol, 2001, 9(4) : 249-257.
  • 7Darren J K, Yuan Z, Claire H, et al. Protein kinase C-β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension [J]. Diabetes, 2003, 52(2): 512-518.
  • 8Wahab N A, Weston B S, Mason R M. Modulation of the TGF-beta/Smad signaling pathway in mesangial cells by CTGF/CCN2 [J]. Exp Cell Res, 2005, 307(2): 305-314.
  • 9Furlong F, Crean J, Thornton L, et al. Dysregulated intracellular signaling impairs CTGF stimulated responses in human mesangial cells exposed to high extracellular glucose [J]. Am J Physiol Renal Physiol, 2007, 292 (6): 1691-1700.
  • 10Derubertis F R,Craven P A.Activation of protein kinase C in glomerular cells in diabetes [J].Diabetes,1994,43 (1):1-7.

共引文献33

同被引文献33

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部